# TIANYIN PHARMACEUTICAL CO., INC.

TIANYIN PHARMACEUTICAL CO., INC. is a company headquartered in Chengdu, P.R., China.

## Company overview

- **Legal name:** TIANYIN PHARMACEUTICAL CO., INC.
- **Former names in filing history:** VISCORP, INC. (2006-06-26 to 2008-03-04)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Chengdu, P.R., China
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001362718

## About

TIANYIN PHARMACEUTICAL CO., INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001362718, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-12-09, it reported annual revenue of USD 46,555,021; net income of USD -644,952; total assets of USD 106,857,849 for the fiscal period ended 2014-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-06-30)

- **Revenue:** $46.6M (USD 46,555,021)
- **Net income:** -$644,952 (USD -644,952)
- **Total assets:** $106.9M (USD 106,857,849)
- **Cash and equivalents:** $16.1M (USD 16,120,041)
- **Operating cash flow:** $2.5M (USD 2,455,283)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-06-30)

- **Revenue:** $67.5M (USD 67,500,476)
- **Net income:** $6.7M (USD 6,672,151)
- **Total assets:** $110.1M (USD 110,143,904)
- **Cash and equivalents:** $26.8M (USD 26,827,008)
- **Operating cash flow:** $8.2M (USD 8,246,083)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-06-30)

- **Revenue:** $69.6M (USD 69,605,758)
- **Net income:** $6.4M (USD 6,358,690)
- **Total assets:** $104.3M (USD 104,317,539)
- **Cash and equivalents:** $35.2M (USD 35,152,295)
- **Operating cash flow:** $8.0M (USD 7,950,214)

## Recent SEC filings

- Form 8-K — filed 2016-05-05 — period 2016-04-29 — CURRENT REPORT
- Form 8-K — filed 2016-04-07 — period 2016-04-01 — CURRENT REPORT
- Form 8-K — filed 2016-03-02 — period 2016-02-25 — CURRENT REPORT
- Form SC 13G — filed 2016-02-17
- Form 8-K — filed 2015-12-02 — period 2015-11-25 — CURRENT REPORT
- Form 8-K — filed 2015-10-19 — period 2015-10-16 — CURRENT REPORT
- Form 8-K — filed 2015-10-16 — period 2015-09-30 — CURRENT REPORT
- Form 8-K — filed 2015-09-22 — period 2015-09-22 — CURRENT REPORT
- Form 8-K — filed 2015-08-11 — period 2015-08-06 — CURRENT REPORT
- Form 10-Q — filed 2015-08-11 — period 2015-03-31 — QUARTERLY REPORT
- Form 8-K — filed 2015-07-17 — period 2015-07-13 — CURRENT REPORT
- Form 8-K — filed 2015-07-14 — period 2014-10-29 — CURRENT REPORT

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/tianyin-pharmaceutical-co-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology